Pipeline Analysis

To help increase the efficiency of country-level planning around the introduction of new health technologies into health systems, the ADP has published an initial pipeline product analysis of new health technologies for malaria, tuberculosis (TB) and selected neglected tropical diseases (NTDs). The report is the outcome of an extensive literature review and key informant interviews, which sought to identify the products most likely to enter the market by 2020. We hope it serves as a valuable resource for policy-makers and other stakeholders involved in health programme planning.

Because the pipeline of new health technologies is evolving continuously, the information is published as a working paper. This acknowledges the need for recurrent updates to make help ensure an accurate picture of this changing landscape.

We invite you to share comments and feedback on the current pipeline analysis, as well as any submit observations or latest research data/publications you may be aware of regarding individual products, relevant research developments and/or related markets.

Please share your comments below or by email to pipeline@adphealth.org